1. Equates to being at high risk for adverse cardiac events with continued medical therapy.
2. Supports consideration for LVAD use or transplant listing based on anticipated projected benefits and risks.
3. Prompts a trigger for an advanced HF cardiac therapy evaluation.
- 1.00 AMA PRA Category 1 Credit™
- 1.00 Participation